Gene · 6520
Papers4,329
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,329
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural basis for the inhibition mechanism of LAT1-4F2hc complex by JPH203. | Cell Discov | 2024 | 38956038 | PubTator, text mining | PubMed |
| Harnessing host enhancers of SARS-CoV-2 entry as novel targets for antiviral therapy. | Antiviral Res | 2024 | 38945485 | PubTator, text mining | PubMed |
| The phenol red compound: A potential artifact in pharmacological induction of ferroptosis. | Free Radic Biol Med | 2024 | 38944214 | PubTator, text mining | PubMed |
| CD147 regulates the formation and function of immune synapses. | Cell Immunol | 2024 | 38909549 | PubTator, text mining | PubMed |
| Trichostatin A Promotes Cytotoxicity of Cisplatin, as Evidenced by Enhanced Apoptosis/Cell Death Markers. | Molecules | 2024 | 38893499 | PubTator, text mining | PubMed |
| Evidence for a relationship between genetic polymorphisms of the L-DOPA transporter LAT2/4F2hc and risk of hypertension in the context of chronic kidney disease. | BMC Med Genomics | 2024 | 38890684 | PubTator, text mining | PubMed |
| Identification and Construction of a Disulfidptosis-Mediated Diagnostic Model and Associated Immune Microenvironment of Osteoarthritis from the Perspective of PPPM. | J Inflamm Res | 2024 | 38882183 | PubTator, text mining | PubMed |
| Strategies for enhanced gene delivery to the central nervous system. | Nanoscale Adv | 2024 | 38868835 | PubTator, text mining | PubMed |
| Effect of 3D and 2D cell culture systems on trophoblast extracellular vesicle physico-chemical characteristics and potency. | Front Cell Dev Biol | 2024 | 38835509 | PubTator, text mining | PubMed |
| Transporter Protein Expression of Corneal Epithelium in Rabbit and Porcine: Evaluation of Models for Ocular Drug Transport Study. | Mol Pharm | 2024 | 38809137 | PubTator, text mining | PubMed |
| Propofol has the potential to resist ferroptosis of neural progenitors by up-regulating SLC3A2. | Asian J Surg | 2024 | 38777644 | PubTator, text mining | PubMed |
| ANO6 (TMEM16F) inhibits gastrointestinal stromal tumor growth and induces ferroptosis. | Open Med (Wars) | 2024 | 38756246 | PubTator, text mining | PubMed |
| FOXC1 regulates endothelial CD98 (LAT1/4F2hc) expression in retinal angiogenesis and blood-retina barrier formation. | Nat Commun | 2024 | 38755144 | PubTator, text mining | PubMed |
| Empagliflozin drives ferroptosis in anoikis-resistant cells by activating miR-128-3p dependent pathway and inhibiting CD98hc in breast cancer. | Free Radic Biol Med | 2024 | 38734268 | PubTator, text mining | PubMed |
| Protein expression of the amino acid transporter SLC7A5 in tumor tissue is prognostic in early-stage colorectal cancer. | PLoS One | 2024 | 38722983 | PubTator, text mining | PubMed |
| Photothermal and ferroptosis synergistic therapy for liver cancer using iron-doped polydopamine nanozymes. | Colloids Surf B Biointerfaces | 2024 | 38714079 | PubTator, text mining | PubMed |
| A novel SLC3A2-targeting antibody-drug conjugate exerts potent antitumor efficacy in head and neck squamous cell cancer. | Transl Oncol | 2024 | 38703658 | PubTator, text mining | PubMed |
| The complete assembly of human LAT1-4F2hc complex provides insights into its regulation, function and localisation. | Nat Commun | 2024 | 38697966 | PubTator, text mining | PubMed |
| The role of CD98 heavy chain in cancer development. | Histol Histopathol | 2024 | 38695393 | PubTator, text mining | PubMed |
| Genetic polymorphisms and major bleeding risk during vitamin K antagonists treatment: The BLEEDS case-cohort. | Pharmacotherapy | 2024 | 38686648 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6520/papers?page=15